...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Neuro-oncology practice. >Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic
【24h】

Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic

机译：远程医疗评估神经肿瘤学学会举办的:比较巴罗神经学的经验分析研究所和Geisinger健康在2020年COVID-19大流行

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Coronavirus disease 2019 (COVID-19) has grossly affected how we deliver health care and how health care institutions derive value from the care provided. Adapting to new technologies and reimbursement patterns were challenges that had to be met by the institutions while patients struggled with decisions to prioritize concerns and to identify new pathways to care. With the implementation of social distancing practices, telemedicine plays an increasing role in patient care delivery, particularly in the field of neurology. This is of particular concern in our cancer patient population given that these patients are often at increased infectious risk on immunosuppres-sive therapies and often have mobility limitations. We reviewed telemedicine practices in neurology pro- and post-COVID-19 and evaluated the neuro-oncology clinical practice approaches of 2 large care systems, Barrow Neurological Institute and Geisinger Health. Practice metrics were collected for impact on clinic volumes, institutional recovery techniques, and task force development to address COVID-19 specific issues. Neuro-Oncology divisions reached 67% or more of prepandemic capacity (patient visits and slot utilization) within 3 weeks and returned to 90% or greater capacity within 6 weeks of initial closures due to COVID-19.The 2 health systems rapidly and effectively implemented telehealth practices to recover patient volumes. Although telemedicine will not replace the in-person clinical visit, telemedicine will likely continue to be an integral part of neuro-oncologic care. Telemedicine has potential for expanding access in remote areas and provides a convenient alternative to patients with limited mobility, transportation, or other socioeconomic complexities that otherwise challenge patient visit adherence.
机译：2019 (COVID-19)已经严重冠状病毒疾病我们如何提供卫生保健和影响医疗机构获得的价值提供护理。还款模式的挑战当病人遇到的机构在决策优化问题和寻找新途径来治疗。实现社会距离的实践,远程医疗在病人中扮演越来越重要的角色保健,尤其是领域的神经学。癌症病人人口考虑到这些病人常常感染风险增加immunosuppres-sive疗法和经常有移动限制。在神经病学pro - post-COVID-19和实践评估神经肿瘤学学会举办的临床实践方法2的大型医疗系统,巴罗神经学研究所和Geisinger健康。收集实践指标的影响诊所卷,机构的复苏技术和工作组开发来解决COVID-19具体问题。部门prepandemic达到67%或更多容量(病人的访问和槽利用率)在3周内,回到90%或更高能力在6周的最初的闭包COVID-19。有效地实现远程医疗实践病人恢复卷。不会取代面对面的临床访问,远程医疗将继续是一个neuro-oncologic保健的有效组成部分。远程医疗已经扩大的潜力在偏远地区和提供了一个方便的患者选择有限的流动性,交通、或其他社会经济复杂性,否则挑战耐心访问的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号